Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Retinal and Choroidal Microvasculature and Structure Using Multimodal Retinal and Choroidal Imaging in Neurodegenerative Disease: iMIND Research Study

NCT03233646 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03233646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03233646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Retinal and Choroidal Microvasculature and Structure Using Multimodal Retinal and Choroidal Imaging in Neurodegenerative Disease: iMIND Research Study
Lead sponsor
Duke University
Phase
Observational
Overall status
Recruiting
Start date
July 20, 2017
Completion date
December 31, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, amyotrophic lateral sclerosis (als), apoe-4 positive, concussion, down syndrome, frontotemporal dementia, huntington disease, lewy body dementia, mild cognitive impairment, multiple sclerosis, neuro-degenerative disease, normal cognition, parkinson's disease, post-traumatic stress disorder, traumatic brain injury